LifeStance Health Group, Inc. revised earnings guidance for the full year of 2023. The company is raising full year revenue and center margin guidance, with the following outlook for 2023: The company expects full year revenue of $1.01 billion to $1.04 billion and Center Margin of $280 million to $300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.565 USD | +1.00% | -3.22% | -28.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.93% | 2.11B | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- LFST Stock
- News LifeStance Health Group, Inc.
- LifeStance Health Group, Inc. Revises Earnings Guidance for the Full Year of 2023